Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Clinical Trial Equipment & Ancillary Solutions Market 2026-2032 - Decentralized and Hybrid Clinical Trials Propel Demand for Advanced Monitoring and Flexible Logistics Solutions

globenewswire.com
AVTR Avantor, Inc. is listed as a key player in the clinical trial equipment and ancillary solutions market. The article provides a market overview and growth forecast, but does not offer specific sentiment towards Avantor's performance. BIO CRL Charles River Laboratories International, Inc. is listed as a company within the clinical trial equipment and ancillary solutions market. The article discusses market growth and trends, but does not offer specific sentiment for this company. IVZ IQVIA Holdings Inc. is identified as a company in the clinical trial equipment and ancillary solutions market. The article focuses on the overall market's growth and transformation, not providing specific sentiment for IQVIA. ORCL Oracle Corporation is mentioned as a player in the clinical trial equipment and ancillary solutions market. The article's focus is on market dynamics and growth, not on specific company performance or sentiment. PKX Paraxel International Corporation is listed as a company within the clinical trial equipment and ancillary solutions market. The article discusses market trends and growth, but does not provide specific sentiment for Paraxel. TMO Thermo Fisher Scientific, Inc. is named as a participant in the clinical trial equipment and ancillary solutions market. The article provides a market overview and growth forecast, but no specific sentiment towards Thermo Fisher. UPS United Parcel Service, Inc. is mentioned in the context of the clinical trial equipment and ancillary solutions market, likely due to its logistics services. The article focuses on market growth, not specific sentiment for UPS. VEEV Veeva Systems Inc. is listed as a company within the clinical trial equipment and ancillary solutions market. The article discusses market trends and growth, but does not offer specific sentiment for Veeva.

Dublin, Jan. 22, 2026 (GLOBE NEWSWIRE) -- The "Clinical Trial Equipment & Ancillary Solutions Market - Global Forecast 2026-2032" report has been added to ResearchAndMarkets.com's offering.

The clinical trial equipment and ancillary solutions market is transforming rapidly as organizations adapt to digitalization, diverse trial models, and evolving compliance requirements. Strategic decision-makers require up-to-date insight into technological integration, procurement resilience, and regulatory shifts impacting operational performance and growth.

Market Snapshot: Clinical Trial Equipment & Ancillary Solutions Market

The Clinical Trial Equipment & Ancillary Solutions Market grew from USD 5.00 billion in 2025 to USD 5.46 billion in 2026. It is expected to continue growing at a CAGR of 10.05%, reaching USD 9.78 billion by 2032. This growth reflects the convergence of technology platforms, the evolution of decentralized and hybrid trial models, and a renewed focus on resilient, patient-centric operations across global clinical development.

Scope & Segmentation

This report covers the full spectrum of the clinical trial equipment and ancillary solutions market, framing drivers and barriers shaping organizational strategy.

Key Takeaways for Senior Decision-Makers

Why This Report Matters

Key Attributes

Key Topics Covered

1. Preface

2. Research Methodology

3. Executive Summary

3.1. Introduction

3.2. CXO Perspective

3.3. Market Size & Growth Trends

3.4. Market Share Analysis, 2025

3.5. FPNV Positioning Matrix, 2025

3.6. New Revenue Opportunities

3.7. Next-Generation Business Models

3.8. Industry Roadmap

4. Market Overview

4.1. Introduction

4.2. Industry Ecosystem & Value Chain Analysis

4.2.1. Supply-Side Analysis

4.2.2. Demand-Side Analysis

4.2.3. Stakeholder Analysis

4.3. Porter's Five Forces Analysis

4.4. PESTLE Analysis

4.5. Market Outlook

4.5.1. Near-Term Market Outlook (0-2 Years)

4.5.2. Medium-Term Market Outlook (3-5 Years)

4.5.3. Long-Term Market Outlook (5-10 Years)

4.6. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective

5.2. Consumer Experience Benchmarking

5.3. Opportunity Mapping

5.4. Distribution Channel Analysis

5.5. Pricing Trend Analysis

5.6. Regulatory Compliance & Standards Framework

5.7. ESG & Sustainability Analysis

5.8. Disruption & Risk Scenarios

5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Clinical Trial Equipment & Ancillary Solutions Market, by Component

8.1. Ancillary Solutions

8.1.1. Central Lab Services

8.1.2. Clinical Trial Management Systems (CTMS)

8.1.3. Data Management & Analytics Services

8.1.4. Electronic Data Capture (EDC) Systems

8.1.5. Interactive Response Technology (IRT)

8.1.6. Patient Engagement Solutions

8.1.7. Supply Chain & Logistics Solutions

8.2. Equipments

8.2.1. Drug Dispensing/Packaging Devices

8.2.2. Imaging Equipment

8.2.3. Laboratory Instruments

8.2.4. Monitoring Device

9. Clinical Trial Equipment & Ancillary Solutions Market, by Phase

9.1. Phase I

9.2. Phase II

9.3. Phase III

9.4. Phase IV

10. Clinical Trial Equipment & Ancillary Solutions Market, by Therapeutic Area

10.1. Cardiology

10.2. Immunology

10.3. Infectious Diseases

10.4. Neurology

10.5. Oncology

11. Clinical Trial Equipment & Ancillary Solutions Market, by End-User

11.1. Academic/Research Institutions

11.2. Biotechnology Firms

11.3. Contract Research Organizations (CROs)

11.4. Medical Device Companies

11.5. Pharmaceutical Companies

12. Clinical Trial Equipment & Ancillary Solutions Market, by Region

12.1. Americas

12.1.1. North America

12.1.2. Latin America

12.2. Europe, Middle East & Africa

12.2.1. Europe

12.2.2. Middle East

12.2.3. Africa

12.3. Asia-Pacific

13. Clinical Trial Equipment & Ancillary Solutions Market, by Group

13.1. ASEAN

13.2. GCC

13.3. European Union

13.4. BRICS

13.5. G7

13.6. NATO

14. Clinical Trial Equipment & Ancillary Solutions Market, by Country

14.1. United States

14.2. Canada

14.3. Mexico

14.4. Brazil

14.5. United Kingdom

14.6. Germany

14.7. France

14.8. Russia

14.9. Italy

14.10. Spain

14.11. China

14.12. India

14.13. Japan

14.14. Australia

14.15. South Korea

15. United States Clinical Trial Equipment & Ancillary Solutions Market

16. China Clinical Trial Equipment & Ancillary Solutions Market

17. Competitive Landscape

17.1. Market Concentration Analysis, 2025

17.1.1. Concentration Ratio (CR)

17.1.2. Herfindahl Hirschman Index (HHI)

17.2. Recent Developments & Impact Analysis, 2025

17.3. Product Portfolio Analysis, 2025

17.4. Benchmarking Analysis, 2025

17.5. Almac Group Limited

17.6. Ancillare, LP

17.7. Avantor, Inc.

17.8. Axelerist

17.9. B. Braun SE

17.10. Bio-Rad Laboratories, Inc.

17.11. Charles River Laboratories International, Inc.

17.12. Dassault Systemes SE

17.13. Emsere B.V.

17.14. Eppendorf SE

17.15. Eurofins Scientific SE

17.16. Global Vision Technologies, Inc.

17.17. Hitachi, Ltd.

17.18. IQVIA Holdings Inc.

17.19. Lonza Group Ltd.

17.20. MedNet Solutions, Inc.

17.21. Myonex, Inc.

17.22. Oracle Corporation

17.23. Parexel International Corporation

17.24. Quanticate International Limited

17.25. Quipment SAS

17.26. Thermo Fisher Scientific, Inc.

17.27. United Parcel Service, Inc.

17.28. Veeva Systems Inc.

17.29. Yokogawa Electric Corporation

17.30. Zifo Technologies Private Limited

For more information about this report visit https://www.researchandmarkets.com/r/cfefo0

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment